About the Authors
- Eleonora Cimini
-
Affiliation Cellular Immunology Laboratory, National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S, Rome, Italy
- Cécile Bonnafous
-
Affiliation Innate Pharma, Marseille, France
- Veronica Bordoni
-
Affiliation Cellular Immunology Laboratory, National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S, Rome, Italy
- Eleonora Lalle
-
Affiliation Virology Laboratory, National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S, Rome, Italy
- Helene Sicard
-
Affiliation Innate Pharma, Marseille, France
- Alessandra Sacchi
-
Affiliation Cellular Immunology Laboratory, National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S, Rome, Italy
- Giulia Berno
-
Affiliation Cellular Immunology Laboratory, National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S, Rome, Italy
- Cristiana Gioia
-
Affiliation Cellular Immunology Laboratory, National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S, Rome, Italy
- Gianpiero D’Offizi
-
Affiliation Clinical Department, National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S, Rome, Italy
- Ubaldo Visco Comandini
-
Affiliation Clinical Department, National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S, Rome, Italy
- Chrysoula Vlassi
-
Affiliation Clinical Department, National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S, Rome, Italy
- Maria Rosaria Capobianchi
-
Affiliation Virology Laboratory, National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S, Rome, Italy
- Federico Martini
-
* E-mail: federico.martini@inmi.it
Affiliation Cellular Immunology Laboratory, National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S, Rome, Italy
- Chiara Agrati
-
Affiliations Cellular Immunology Laboratory, National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S, Rome, Italy, Virology Laboratory, National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S, Rome, Italy
Competing Interests
The authors have read the journal’s policy and have the following conflicts: CB and HS are employed in Innate Pharma (Marseille, France). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: CB VB EL HS FM CA. Performed the experiments: EC VB EL GB CA. Analyzed the data: EC VB AS GB CG MRC CA. Contributed reagents/materials/analysis tools: CB HS. Wrote the paper: EC VB FM CA. Patient management: GD UVC CV.